Cogent Biosciences, Inc.

Aaron Christopher Smith

Mark Joseph Chicarelli

Martha E Rodriguez

Logan E Vine

Jennifer Fulton

Leah J Salituro

Ravi Kumar Jalluri

Bradley J Newhouse

John E Robinson

Jay Bradford Fell

Macedonio J Mejia

Robert A Rieger

Tanna Bettendorf

Scott W Niman

Patrick J Sutter

Paul R Carlson

Brooklynn Venteicher

Yeyun Zhou

John I Trujillo

Vijay Kumar

Hailey J Knox

Michael L Conner

Lee M Stunkard

Payal Chatterjee

Cori A Malinky

A compound having the following structure of Formula (IV): or a stereoisomer, salt, or tautomer thereof, wherein R, R, R, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.

Compounds for FGFR inhibition

A compound having the following structure of Formula (I): or a stereoisomer of the compound, tautomer of the compound, pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, A, X, Z, and Y are as defined herein.Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.

PI3K inhibitors

Growing community of inventors

Boulder, CO, United States of America

Aaron Christopher Smith